Clinical Trials
3 trialsNCT03697577 2026-05-29
CDK and Body Composition Study
Montefiore Medical Center
Active not recruiting
NCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
NCT02297672 2026-02-02
PBSI
British Columbia Cancer Agency
Phase NA Active not recruiting